Clinical Trial Update: Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma

View source ↗

Summary

This entry updates a trial evaluating a multimodal kidney-sparing strategy for high-risk upper tract urothelial carcinoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Snippet

Sponsor: Peking University First Hospital | Conditions: Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy, Upper Tract Urothelial Carcinoma | Status: NOT_YET_RECRUITING